Advisory Board and Editors Internal Medicine
Joshua S Davis
Josh is a clinician researcher, and divides his time between clinical work as an Infectious Diseases physician in Newcastle, and research work as a principal research fellow based at Menzies.
He completed his clinical infectious diseases training in 2004, and then worked on a PhD from 2007-2010 on the epidemiology, pathophysiology and adjunctive treatment of sepsis in the Top End of the Northern Territory (NT).
His main clinical interests are general infectious diseases, viral hepatitis, refugee health and infections in the critical care setting. His main research interests are clinical trials in the management of severe infections and epidemiology of severe bacterial infections.
Josh is the past president of the Australasian Society for Infectious Diseases (ASID) and is a career development fellow of Australia's National Health and Medical Research Council. In the 10 years since completing his PhD, he has over 140 peer-reviewed publications and an h-index of 31.
Peixin Dong
Dr. Dong Peixin is currently working on the roles of genetic and epigenetic mechanisms (especially non-coding RNA networks) underlying cancer stem cells, EMT, chemoresistance and cancer metastasis in Obstetrics and Gynecology, Hokkaido University, Japan. Dr. Dong has published more than 70 papers in international journals. Dr. Dong has been serving as Associate Editors of Frontiers in Pharmacology, Frontiers in Oncology, BMC Cancer, All Life, Journal of Cellular and Molecular Medicine, European Journal of Medical Research, Current Gene Therapy, and Editorial Board members of PeerJ, Clinical & Experimental Metastasis, PLOS ONE, Genes, Biomolecules, Bioengineered, Chinese Clinical Oncology, and Gynecology and Pelvic Medicine. Dr. Dong is the recipient of multiple awards.
Chengming Fan
Prf. Chengming Fan is a Surgeon in the Department of Cardiovascular Surgery at Central South University. HIs current basic research interests include treatment of ischemic heart disease with human induced pluripotent stem cells (hiPSC)-related strategy and with preclinical animal models.
Tamas Fulop
Dr. Tamàs Fülöp is Assistant Director of the Age Research Centre and Full Professor within the Faculty of Medicine and Health Sciences at the Université de Sherbrooke in Quebec, Canada. He is also Head of the Immune Inflammation Laboratory and Medical Director of the Memory Clinic.
M.D: From the Unversity of Geneva.
His postdoctoral research was in the biochemistry of connective tissues, and his PhD is in immunology and gerontology. His research interest is aging in relation to immunity.
Bang-Gee Hsu
Dr. Bang-Gee Hsu obtained his MD from the Chinese Medical University, Taichung, Taiwan (1989 - 1996) and his PhD from the Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan (2003-2006).
Dr. Hsu is currently Professor at the School of Medicine, Tzu Chi University, Hualien, Taiwan (2015-present), Director of the Department of Internal Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan (2018-present), and Director of the Division of Nephrology Department of Internal Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan (2014-present).
His research interests include Nephrology, Critical Care Medicine and Internal Medicine.
Lei Huang
Dr. Lei Huang is a cancer epidemiologist, translational oncologist, digestive surgeon, surgical oncologist, and gastroenterologist. He has published about 50 papers in SCI(E)-indexed journals including Gut, Annals of Surgery, BMC Medicine, JAMA Surgery, Clinical Cancer Research, Cancer Immunology Research, International Journal of Cancer, EBioMedicine, and Gastric Cancer. His works have been cited for about 1000 times.
Dr. Huang has served on the editorial board of Frontiers in Oncology, World Journal of Gastrointestinal Oncology, PeerJ, Medicine, and Translational Cancer Research, and Frontiers in Surgery. He has been peer reviewer for about 50 SCI(E)-indexed journals including Annals of Internal Medicine, Annals of Surgery, Clinical Cancer Research, Journal of the National Comprehensive Cancer Network-JNCCN, Cancer Letters, Oncoimmunology, and Oncologist. He was selected as Best Reviewer for Annals of Internal Medicine twice in 2017 and 2019.
Dr. Huang has been invited to give oral presentations in the ASCO Annual Meeting and International Gastric Cancer Congress (IGCC), and has received Merit Awards in the ESMO Annual Meeting and Awards for Young Investigators in the IGCC.
His research interests majorly cover the epidemiological, clinical, and translational aspects of digestive cancers. He has successfully coordinated several large international investigations with participants from the US and about 20 European countries.
Randal J. Kaufman
Professor and Director of the Degenerative Diseases at the Sanford-Burnham Medical Research Institute, La Jolla, CA. Formerly Professor of Biological Chemistry and Internal Medicine and Investigator of the Howard Hughes Medical Research Institute at the University of Michigan Medical School. Awards include the Murray Thelin Award, the ìPrix Henri Chaigneauî, the ISTH Investigator Recognition Award , the ESACT Van Wezel Prize, and fellow of the AAAS.
Yoshinori Marunaka
Prof. Marunaka is the President and the Representative Director, Director of Clinical, and Director of Medical Research Institute, Kyoto Industrial Health Association; Professor, Research Organization of Science and Technology, Ritsumeikan University; Professor Emeritus, Kyoto Prefectural University of Medicine; Former President, Physiological Society of Japan. Former President, International Society of Cancer Metabolism. MD (1979), PhD (1985), Kyoto Prefectural University of Medicine; National License of Physician and Surgeon, Japan (1979). He was Professor and Chairperson, Departments of Molecular Cell Physiology and Bio-Ionomics, Kyoto Prefectural University of Medicine, Japan, and Director and Professor, Japan Institute for Food Education and Health, St. Agnes’ University. He was awarded “Vebleo Nanomedicine Scientist Award” (Sweden), “Marco Polo della Scienza Italiana” (Italy), The Premier's Research Excellence Award (Canada), Scholar Award (Medical Research Council of Canada) and Research Award from National Kidney Foundation of USA. He has obtained more than 60 research grants, published more than 270 peer reviewed articles, and provided more than 30 invited plenary lectures at international congresses and research conferences. h-index 47, i10-index 190, Citation 7498
Ghanshyam Palamaner Subash Shantha
Dr. Ghanshyam Palamaner Subash Shantha is an academic cardiac electrophysiologist and faculty physician at Wake Forest University. His clinical interests include atrial fibrillation, leadless pacemakers and ventricular tachycardia management, and his research interests include epidemiology and prevention of diseases.
Feng Pan
Dr. Pan is a Senior Research Fellow at Menzies Institute for Medical Research. He has been researching both epidemiology and clinical interventions to osteoarthritis-related pain. Much of his work has been on identifying biomechanical risk factors for chronic pain and osteoarthritis, identifying pain and osteoarthritis phenotypes and testing new therapeutic treatments.
Teresa M Seccia
Associate Professor in Internal Medicine, Dept. Medicine, University of Padova, Italy.
International PhD Degree in 'Arterial Hypertension and Vascular Biology'.
Field of interest: Clinical and translational research in high blood pressure and cardiovascular diseases.
Rajesh Kumar Singh
Dr. Rajesh Kumar Singh was born in 1980. He received his B. Pharmacy (2003) and M. Pharmacy (2005) from UIPS, Panjab University, Chandigarh. He completed his PhD in 2013 from IKG Punjab Technical University (IKGPTU), Jalandhar.
Dr. Singh’s major area of research interests are synthetic medicinal chemistry, polymer-drug conjugates for targeted delivery, Antimalarial and CNS active therapeutic agents and green chemistry approaches for chemical synthesis of pharmaceutical molecules.
Dr. Singh has over 14 years of teaching experience, guided 18 PG and 01 Ph.D. students and currently guiding 02 PhD students. He has published more than 60 peer-reviewed scientific research papers in SCI indexed various Chemistry and Pharmacy Journals of impact factor 1.5 to 4.8 as the main or corresponding author.
Dr. Singh is Editorial Board Member of SCOPUS indexed 06 Int. Journals. He has received Publon Award 2016, 2017 and Publon “Excellent Peer Reviewer award” for outstanding reviewing more than 120 research papers of different International Journals of ACS, RSC, Springer, Elsevier, Dove, Informa and Bentham of Impact Factor varies from 1.0 to 8.5. He has also to his credit more than 50 National and International Conference Abstracts, 2 Books, 5 Best Paper Presentation Awards, 1 Travel grant to attend Int. Conf. and 5 Research Projects funded by various government funding agencies.